Epiroc AB (publ)
Epiroc AB (publ), together with its subsidiaries, develops and produces equipment for use in surface and underground applications in North America, Europe, South America, Europe, Africa, the Middle East, Asia, Australia, and India. It operates in two segments, Equipment & Service, and Tools & Attachments. The Equipment & Service segment provides equipment and solutions for rock drilling, rock exc… Read more
Epiroc AB (publ) (EPIAF) - Total Liabilities
Latest total liabilities as of December 2025: $38.10 Billion USD
Based on the latest financial reports, Epiroc AB (publ) (EPIAF) has total liabilities worth $38.10 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Epiroc AB (publ) - Total Liabilities Trend (2015–2025)
This chart illustrates how Epiroc AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Epiroc AB (publ) Competitors by Total Liabilities
The table below lists competitors of Epiroc AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Albemarle Corp
NYSE:ALB
|
USA | $6.59 Billion |
|
Suzhou Dongshan Precision Manufacturing Co Ltd
SHE:002384
|
China | CN¥30.53 Billion |
|
Hana Financial
KO:086790
|
Korea | ₩614.08 Trillion |
|
Expeditors International of Washington, Inc.
NASDAQ:EXPD
|
USA | $2.50 Billion |
|
SBA Communications Corp
NASDAQ:SBAC
|
USA | $16.12 Billion |
|
Wanhua Chemical Group Co Ltd
SHG:600309
|
China | CN¥211.99 Billion |
|
WuXi AppTec Co. Ltd
PINK:WUXIF
|
USA | $23.12 Billion |
|
Moderna Inc
NASDAQ:MRNA
|
USA | $3.69 Billion |
Liability Composition Analysis (2015–2025)
This chart breaks down Epiroc AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Epiroc AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Epiroc AB (publ) (2015–2025)
The table below shows the annual total liabilities of Epiroc AB (publ) from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $38.10 Billion | -5.70% |
| 2024-12-31 | $40.41 Billion | +32.17% |
| 2023-12-31 | $30.57 Billion | +8.14% |
| 2022-12-31 | $28.27 Billion | +24.01% |
| 2021-12-31 | $22.80 Billion | +13.16% |
| 2020-12-31 | $20.15 Billion | +10.55% |
| 2019-12-31 | $18.22 Billion | +5.29% |
| 2018-12-31 | $17.31 Billion | +13.47% |
| 2017-12-31 | $15.25 Billion | +7.64% |
| 2016-12-31 | $14.17 Billion | +5.06% |
| 2015-12-31 | $13.49 Billion | -- |